Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer - Porter, C; Armstrong-Fisher, S; Kopotsha, T (J Reprod Immunol, 2016)
et al.